Skip to content
PIL Logo

Colobreathe

Last Updated on eMC 11-Jul-2017 View document  | Teva UK Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11-Jul-2017 and displayed until Current

Reasons for adding or updating:

  • Improved presentation of PIL

Updated on 30-Sep-2016 and displayed until 11-Jul-2017

Reasons for adding or updating:

  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - warnings and precautions
  • Correction of spelling/typing errors
  • Improved presentation of PIL

Updated on 20-Jul-2015 and displayed until 30-Sep-2016

Reasons for adding or updating:

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 01-Oct-2014 and displayed until 20-Jul-2015

Reasons for adding or updating:

  • Change to section 3 - how to take/use
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 18-Dec-2013 and displayed until 01-Oct-2014

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision

Updated on 12-Aug-2013 and displayed until 18-Dec-2013

Reasons for adding or updating:

  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Updated on 11-Jun-2013 and displayed until 12-Aug-2013

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Teva UK Limited

Company image
Address

Field House, Station Approach, Harlow, Essex, CM20 2FB

Fax

+44 (0)207 540 7169

Medical Information e-mail
Telephone

+44 (0)207 540 7000

Medical Information Direct Line

+44 (0)207 540 7117

Medical Information Fax

+44 (0)207 540 7349

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

colistimethate sodium

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue